|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1993-4-15
|
|
pubmed:abstractText |
Gemcitabine, 2'2'difluoro-deoxycytidine (dFdC), has shown activity in several preclinical models, and presently the compound is being clinically evaluated in patients with lung cancer and other solid tumors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
4
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
157-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8383519-Animals,
pubmed-meshheading:8383519-Antimetabolites, Antineoplastic,
pubmed-meshheading:8383519-Carcinoma, Small Cell,
pubmed-meshheading:8383519-Deoxycytidine,
pubmed-meshheading:8383519-Fluorine,
pubmed-meshheading:8383519-Humans,
pubmed-meshheading:8383519-Lung Neoplasms,
pubmed-meshheading:8383519-Magnetic Resonance Spectroscopy,
pubmed-meshheading:8383519-Mice,
pubmed-meshheading:8383519-Mice, Nude,
pubmed-meshheading:8383519-Neoplasm Transplantation
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Intratumoral pharmacokinetic analysis by 19F-magnetic resonance spectroscopy and cytostatic in vivo activity of gemcitabine (dFdC) in two small cell lung cancer xenografts.
|
|
pubmed:affiliation |
Department of Oncology, Finsen Institute-Rigshospitalet, University of Copenhagen, Denmark.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
